#Tag

FDA

2 articles on FDA

AstraZeneca shares plunge after FDA panel rejects its treatment

The British pharmaceutical company's stock fell 2% following the U.S. advisory committee's negative vote on camizestrant, a key drug expected to generate $5 billion in sales.

Rédaction ActuTradingil y a environ 2 mois

Actions

Replimune collapses after FDA refuses to approve its melanoma treatment

Replimune plummets 59% following the announcement of the FDA's refusal. The biotech will have no choice but to drastically reduce its operations.

Rédaction ActuTradingil y a 3 mois

AstraZeneca shares plunge after FDA panel rejects its treatment

Replimune collapses after FDA refuses to approve its melanoma treatment

Related topics